Earnings Preview: Vanda Pharmaceuticals
Vanda Pharmaceuticals (NASDAQ:VNDA) is set to give its latest quarterly earnings report on Wednesday, 2023-02-08. Here’s what investors…
Vanda Pharma’s Antipsychotic Shows Improved Severity In Bipolar Disorder
Vanda Pharmaceuticals Inc (NASDAQ:VNDA) reported results from a Phase 3 study of Fanapt (iloperidone tablets), a novel atypical antipsychotic, in acute…
Stocks That Hit 52-Week Lows On Friday
During Friday's trading, 293 companies set new 52-week lows.
JetBlue Airways, Pacira BioSciences And Some Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 70 points on Tuesday. Here are some big stocks recording losses in today’s session.
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Vanda Pharmaceuticals Q3 EPS $0.06 Misses $0.09 Estimate, Sales $65.32M Miss $71.00M Estimate
Vanda Pharmaceuticals (NASDAQ:VNDA) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.09 by 33.33 percent. This is a 57.14 percent decrease over earnings of $0.14 per share